Please login to the form below

Not currently logged in
Email:
Password:

TeneoTwo

This page shows the latest TeneoTwo news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca acquires TeneoTwo in a deal worth up to $1.27bn

AstraZeneca acquires TeneoTwo in a deal worth up to $1.27bn

The acquisition includes TeneoTwo’s phase 1 clinical-stage T-cell engager. In a new deal valued at up to $1.27bn, AstraZeneca (AZ) has acquired biotechnology firm TeneoTwo. ... It has been agreed between the companies that AZ will acquire all

Latest news

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...